EpiAxis appoints Sage Group to lead global partner search

EpiAxis appoints Sage Group to lead global partner search

EpiAxis has appointed The Sage Group to lead the search for a global strategic partner with whom it can collaborate to exploit its new family of oncology drugs. EpiAxis Therapeutics is a rapidly growing, Australian-based pharmaceutical discovery company leading the...

read more
EpiAxis expands Phase 1 metastic breast cancer trial

EpiAxis expands Phase 1 metastic breast cancer trial

EpiAxis Therapeutics has expanded its clinical trial program to include two additional recruitment centres for its Phase 1b metastatic breast cancer program. The centres open for patient recruitment are the Southern Medical Day Care Centre in Wollongong and at the...

read more

 

Professor Sudha Rao